Comment on: Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR): reply

Andrea Rubbert-Roth; Paul P. Tak; Cristiano Zerbini; Jean-Luc Tremblay; Luis Carreño; Gillian Armstrong; Neil Collinson; Tim Shaw

doi:10.1093/rheumatology/keq401

Comment on: Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR): reply

Andrea Rubbert-Roth
, Paul P. Tak
, Cristiano Zerbini
, Jean-Luc Tremblay
, Luis Carreño
, Gillian Armstrong
, Neil Collinson
, Tim Shaw

Affiliatie UvA

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	632-633
Journal	Rheumatology (Oxford, England)
Volume	50
Issue number	3
DOIs	https://doi.org/10.1093/rheumatology/keq401
Publication status	Published - 2011

Access to Document

10.1093/rheumatology/keq401

Cite this

Rubbert-Roth, A., Tak, P. P., Zerbini, C., Tremblay, J.-L., Carreño, L., Armstrong, G., Collinson, N., & Shaw, T. (2011). Comment on: Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR): reply. Rheumatology (Oxford, England), 50(3), 632-633. https://doi.org/10.1093/rheumatology/keq401

@article{965e68c9a5c24814a92ce809f6dbb1ea,

title = "Comment on: Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR): reply",

author = "Andrea Rubbert-Roth and Tak, \{Paul P.\} and Cristiano Zerbini and Jean-Luc Tremblay and Luis Carre{\~n}o and Gillian Armstrong and Neil Collinson and Tim Shaw",

year = "2011",

doi = "10.1093/rheumatology/keq401",

language = "English",

volume = "50",

pages = "632--633",

journal = "Rheumatology (Oxford, England)",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "3",

}

Rubbert-Roth, A, Tak, PP, Zerbini, C, Tremblay, J-L, Carreño, L, Armstrong, G, Collinson, N & Shaw, T 2011, 'Comment on: Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR): reply', Rheumatology (Oxford, England), vol. 50, no. 3, pp. 632-633. https://doi.org/10.1093/rheumatology/keq401

Comment on: Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR): reply. / Rubbert-Roth, Andrea; Tak, Paul P.; Zerbini, Cristiano et al.
In: Rheumatology (Oxford, England), Vol. 50, No. 3, 2011, p. 632-633.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Comment on: Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR): reply

AU - Rubbert-Roth, Andrea

AU - Tak, Paul P.

AU - Zerbini, Cristiano

AU - Tremblay, Jean-Luc

AU - Carreño, Luis

AU - Armstrong, Gillian

AU - Collinson, Neil

AU - Shaw, Tim

PY - 2011

Y1 - 2011

U2 - 10.1093/rheumatology/keq401

DO - 10.1093/rheumatology/keq401

M3 - Comment/Letter to the editor

C2 - 21172928

SN - 1462-0324

VL - 50

SP - 632

EP - 633

JO - Rheumatology (Oxford, England)

JF - Rheumatology (Oxford, England)

IS - 3

ER -